Avricore Health Inc. (AVCRF)
PNK · Healthcare · Diagnostics & Research
$0.05
-2.14%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$4.6M
Shares Outstanding
101.3M
P/S (TTM)
32.1x
Exchange
PNK
Currency
USD
About Avricore Health Inc.
Avricore Health Inc. engages in the health data and point-of-care technologies businesses in Canada and the United Kingdom. It provides HealthTab, a turnkey point-of-care testing platform for pharmacies that can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. The company was formerly known as Vanc Pharmaceuticals Inc. and changed its name to Avricore Health Inc. in October 2018. Avricore Health Inc. was founded in 1996 and is based in Vancouver, Canada.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 29K | 38K | 33K | 44K |
| Gross Profit | -48K | -53K | -7K | -9K |
| Operating Income | -472K | -379K | -342K | -240K |
| Net Income | -459K | -379K | -943K | -205K |
| Diluted EPS | $0.00 | $0.00 | $nan | $0.00 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 1.8M | 3.5M | 4.8M | 534K |
| Gross Profit | 457K | 1.2M | 1.9M | 238K |
| Operating Income | -813K | -687K | 139K | -1.3M |
| Net Income | -818K | -701K | -669K | -1.9M |
| Diluted EPS | $-0.01 | $-0.01 | $-0.01 | $-0.02 |